Clean & Science Co Financing Cash Flow
The Net Financing Cash Flow of Clean & Science Co (045520.KQ) as of Oct 9, 2026 is -4.99 B KRW. In the previous year, Net Financing Cash Flow was -1.63 B KRW — a change of 206.14% (lower).
Get this data via API
Financial Data API
Financing Cash Flow
-4.99 BKRW
YoY
206.14%
Last updated:
The Clean & Science Co Financing Cash Flow history
3 Years
10 Years
25 Years
Max
| YEAR | Financing Cash Flow | YoY |
|---|---|---|
| -4.99 BKRW | +206.14% | |
| -1.63 BKRW | -208.03% | |
| 1.51 BKRW | -114.38% | |
| -10.50 BKRW | -187.27% | |
| 12.03 BKRW | -35.34% | |
| 18.61 BKRW | +381.62% | |
| 3.86 BKRW | -43.36% | |
| 6.82 BKRW | +632.78% | |
| 931.11 MKRW | +175.62% | |
| 337.83 MKRW | -124.30% | |
| -1.39 BKRW | — |
Clean & Science Co Stock analysis
Frequently Asked Questions about Clean & Science Co stock
Net Financing Cash Flow of Clean & Science Co is -4.99 B KRW in 2024.
Net Financing Cash Flow of Clean & Science Co changed from -1.63 B KRW to -4.99 B KRW, representing a 206.14% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Net Financing Cash Flow Clean & Science Co since 2006 – with annual values, charts, and detailed analysis.
Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.
Net Financing Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Clean & Science Co historically and in real time.
Cash Flow — Clean & Science Co
All Key Metrics — Clean & Science Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth